"Psychedelics Refresh Thinking Processes" | Interview with DAVID NUTT, PhD | ICPR 2022
16 dic 2024 ·
18 min. 16 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
DAVID NUTT, PhD is Professor of Neuropsychopharmacology at the Imperial College London, UK. Recorded at the Interdisciplinary Conference on Psychedelic Research David Nutt (ICPR) 2022, in Haarlem, The Netherlands. https://www.icpr-conference.com/...
mostra di più
DAVID NUTT, PhD is Professor of Neuropsychopharmacology at the Imperial College London, UK. Recorded at the Interdisciplinary Conference on Psychedelic Research David Nutt (ICPR) 2022, in Haarlem, The Netherlands.
https://www.icpr-conference.com/
https://drugreporter.net
Questions: 0:00 Intro 0:05 What will be the heritage of this psychedelic renaissance? 2:26 Can the pharmaceutical industry use psychedelics as modern medicines? 4:23 Can we separate the hallucinogenic effects of psychedelics from the medical benefits? 6:44 What's your view on microdosing? 7:59 How do psychedelics, such as psilocybin compare to traditional antidepressants in treating depression? 10:30 What about Ketamine? How does it compare to psilocybin, how does it affect the brain, and how does it treat depression? 13:05 Can these substances be used outside of their traditional contexts, as modern medicines? 14:52 How do you see the future of psychedelics? What role will they play in mainstream mental health care? 16:10 How can we overcome the scepticism of the general public and scientists, regarding psychedelics?
mostra meno
https://www.icpr-conference.com/
https://drugreporter.net
Questions: 0:00 Intro 0:05 What will be the heritage of this psychedelic renaissance? 2:26 Can the pharmaceutical industry use psychedelics as modern medicines? 4:23 Can we separate the hallucinogenic effects of psychedelics from the medical benefits? 6:44 What's your view on microdosing? 7:59 How do psychedelics, such as psilocybin compare to traditional antidepressants in treating depression? 10:30 What about Ketamine? How does it compare to psilocybin, how does it affect the brain, and how does it treat depression? 13:05 Can these substances be used outside of their traditional contexts, as modern medicines? 14:52 How do you see the future of psychedelics? What role will they play in mainstream mental health care? 16:10 How can we overcome the scepticism of the general public and scientists, regarding psychedelics?
Informazioni
| Autore | Rights Reporter Foundation |
| Organizzazione | Rights Reporter Foundation |
| Sito | youtu.be |
| Tag |
Copyright 2025 - Spreaker Inc. an iHeartMedia Company
Commenti